Controversy and consensus on aspirin for the primary prevention of cardiovascular disease
10.3760/cma.j.issn.0254-9026.2017.11.023
- VernacularTitle:阿司匹林心血管疾病一级预防争议与共识
- Author:
Xiaofang ZHOU
1
Author Information
1. 四川省医学科学院·四川省人民医院老年心血管内科
- Keywords:
Cardiovascular disease;
Aspirin;
Primary prevention
- From:
Chinese Journal of Geriatrics
2017;36(11):1261-1266
- CountryChina
- Language:Chinese
-
Abstract:
Primary prevention is essential to reduction in the morbidity and mortality of cardiovascular disease.Aspirin is one of the important intervention measures for the primary prevention of cardiovascular disease and is cost-effective,and its role has been well confirmed in previous studies.However,the release of negative results in recent years has raised questions about its value for primary prevention.The combined effects of multiple factors have led to discrepancies in different studies.Standardized use of aspirin in qualified population groups for primary intervention in clinical practice should be promoted so that maximum clinical benefits can be achieved.
